Sunscreens

Advances in Experimental Medicine and Biology

Volumn 624, Issue , 2008, Pages 137-161

  Bens, Guido ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COLECALCIFEROL; FERULIC ACID; OLIGONUCLEOTIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTECTIVE AGENT; RETINOL DERIVATIVE; SOLID LIPID NANOPARTICLE; SUNSCREEN;

BASAL CELL CARCINOMA; CANCER RISK; CARCINOGENESIS; COSMETIC INDUSTRY; DRUG EFFICACY; ERYTHEMA; FILTER; FOOD AND DRUG ADMINISTRATION; HUMAN; MELANOMA; PATHOGENESIS; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SKIN PROTECTION; SOLAR RADIATION; SUN EXPOSURE; SUNBURN; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ANIMAL; CHEMISTRY; MOUSE; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; HUMANS; MICE; SKIN NEOPLASMS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 42949138809     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-77574-6_12     Document Type: Review

References (86)

1. Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol 2005; 52:937-58.
2. Schacfcr H, Moyal D, Fourtanicr A. Recent advances in sun protection. Semin Cut Med Surg 1998; 17:266-75.
3. Jeanmougin M. Photodermatoses et photoprotection. Paris: Deltacom, 1983.
4. Young AR. Chromophores in human skin. Phys Med Biol 1997; 42:789-802.
5. Goukassian DA, EUer MS, Yaar M et al. Thymidine dinucleotide mimics the effect of solar-simulated irradiation on p53 and p53-regulated proteins. J Invest Dermatol 1999; 112:25-31.
6. Wolpowitz D, Gilchrest BA. The vitamin D questions: How much do you need and how should you get it? J Am Acad Dermatol 2006; 54:301-17.
7. Pinnell SR. Cutaneous photodamage, oxidative stress and topical antioxidant protection. J Am Acad Dermatol 2003; 48:1-19.
8. Wenczl E, Pool S, Timmerman AJ et al. Physiological doses of ultraviolet irradiation induce DNA strand breaks in cultured human melanocytes, as detected by means of an immunochemical assay. Photochem Photobiol 1997; 66:826-30.
9. Parsons PG, Hayward IP. Inhibition of DNA repair synthesis by sunlight. Photochem Photobiol 1985; 42:287-93.
10. Marrot L, Bclaidi JP, Meunier JR et al. The human melanocyte as a particular target for UVA radiation and an endpoint for photoprotection assessment. Photochem Photobiol 1999; 69:686-93.
11. Mouret S, Baudouin C, Charveron M et al. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole skin exposed to UVA radiation. Proc Natl Acad Sci USA 2006; 103:13765-70.
12. Honigsmann H. Erythema and pigmentation. Photodermatol Photoimmunol Photomed 2002; 18:75-81.
13. Eller MS, Yaar M, Gilchrest BA. DNA damage and melanogenesis. Nature 1994; 372:413-4.
14. Gilchrest BA, Park HY, Eller MS et al. Mechanismes of ultraviolet-induced pigmentation. Photochem Photobiol 1996; 63:1-10.
15. Gange RW, Blackett AD, Matzinger EA et al. Comparative protection efficiency of UVA and UVBinduced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J Invest Dermatol 1985; 85:362-4.
16. Varani J, Spearman D, Perone P et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol 2001; 158:931-42.
17. Kawaguchi Y, Tanaka H, Okada T et al. Effect of reactive oxygen species on the elastin mRNA expression in cultured human dermal fibroblasts. Free Radic Biol Med 1997; 23:192-5.
18. Kelly DA, Young AR, McGregor JM et al. Sensitivity to sunburn is associated with susceptibility to UVR-induced suppression of cutaneous cell-mediated immunity. J Exp Med 2000; 191:561-6.
19. Bestak R, Halliday GM. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell avtivation in C3H/HeJ mice. Photochem Photobiol 1996; 64:969-74.
20. Nghiem DX, Kazimi N, Clydesdale G et al. Ultraviolet A radiation suppresses an established immune response: implications for sunscreen design. J Invest Dermatol 2001; 117:1193-9.
21. DeBuys HV, Levy SB, Murray JC et al. Modern approaches to photoprotection. Dermatol Clin 2000; 18:577-90.
22. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002; 146 Suppl 61:17-9.
23. Ting WW, Vest CD, Sontheimcr R. Practical and experimental consideration of sun protection in dermatology. Int J Dermatol 2003; 42:505-13.
24. Kelly DA, Seed PT, Young AR et al. A commercial sunscreen's protection against ultraviolet radiation- induced immunosuppression is more than 50% lower than protection against simbum in humans. J Invest Dermatol 2003; 120:65-71.
25. Diffey BL, Tanner PR, Marts PJ et al. In vitro assessment of the broad-spectrum ultraviolet protection of sunscreen products. J Am Acad Dermatol 2000; 43:1024-35.
26. Ciba Specialty Chemicals. Ciba Tinosorb® product brochure. Basel, 2002.
27. Szczurko C, Dompmartin A, Michel M et al. Photocontact allergy to oxybenzone: ten years of experience. Photodermatol Photoimmunol Photomed 1994; 10:144-7.
28. Journ F, Marguery MC, Rakotondrazafy J et al. Sunscreen sensitization: a 5-year-study. Acta Derm Venereol 1999; 79:211-3.
29. Bouillon C. Recent advances in sun protection. J Dermatol Sci 2000; 23 Suppl 1:S57-61.
30. Sarveiya V, Risk S, Benson HAE. Liquid chromatographic assay for common sunscreen agents: appUcation to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B 2004; 803:225-31.
31. Janjua NR, Mogcnscn B, Andersson AM ct al. Systemic absorption of the sunscreens benzophenone-3, octyl-mcthoxycinnamate and 3-(4-methyl-benzylidcnc) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004; 123:57-61.
32. Schlumpf M, Cotton B, Conscience M et al. In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 2001; 109:239-44.
33. Brand RM, Pike J, Wilson RM et aL Sunscreens containing physical UV blockers can increase transdermal absorption of pesticides. Toxicol Ind Health 2003; 19:9-16.
34. Pont AR, Charron AR, Brand RM. Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicol Appl Pharmacol 2004; 195:348-54.
35. Sutherland JC, Griffin KP. P-aminobenzoic acid can sensitize the formation of pyrimidine dimers in DNA: direct chemical evidence. Photochem Photobiol 1984; 40:391-4.
36. Gasparro FP, Mitchnick M, Nash JF. A review of sunscreen safety and efficacy. Photochem Photobiol 1998; 68:243-56.
37. Chatelain E, Gabard B. Photostabilization of butyl methoxydibenzoylmethane (avobenzone) and ethylhexyl methoxycinnamate by bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), a new UV broadband filter. Photochem Photobiol 2001; 74:401-6.
38. Ashby J, Tinwell H, Plautz J et al. Lack of binding to isolated estrogen or androgen receptors and inactivity in the immature rat uterotrophic assay, of the ultraviolet sunscreen filters Tinosorb M-active and Tinosorb S. Regul Toxicol Pharmacol 2001; 34:287-91.
39. Moselcy H, Cameron H, MacLeod T et al. New sunscreens confer improved protection for photosensitive patients in the blue Ught region. Br J Dermatol 2001; 145:789-94.
40. Mitchnick MA, Fairhurst D, Pinnell SR. Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent. J Am Acad Dermatol 1999; 40:85-90.
41. Nakagawa Y, Wakuri S, Sakamoto K et al. The photogenotoxicity of titanium dioxide particles. Mutat Res 1997; 394:125-32.
42. Miiller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000; 50:161-71.
43. Villalobos-Hemandez JR, Miiller-Goymann CC. Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: The synergistic interaction between organic and inorganic sunscreens at nanoscale. Int J Pharm 2006; 322:161-70.
44. Wiilf HC, Stender IM, Lock-Andersen J. Sunscreens used at the beach do not protect against erythema: A new definition of SPF is proposed. Photodermatol Photoimmunol Photomed 1997; 13:129-32.
45. Faurschou A, Wulf HC. The relation between sim protection factor and amount of sunscreen applied in vivo. Br J Dermatol 2007; 156:716-9.
46. Diffey BL, Grice J. The influence of sunscreen type on photoprotection. Br J Dermatol 1997; 137:103-5.
47. Phillips TJ, Bhawan J, Yaar M et al. Effect of daily versus intermittent sunscreen application on solar simulated UV-radiation-induced skin response in humans. J Am Acad Dermatol 2000; 43:618-8.
48. Bcani JC. Photoprotection externe. In: Socicte Fran9aisc de Photodermatologie, ed. Photodermatologie. Rueil-Mahnaison: Arnette, 2003: 131-46.
49. Stege H, Budde MA, Grether-Beck S et al. Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test. Photodermatol Photoimmunol Photomed 2000; 16:256-9.
50. Kligman LH, Sayre RM. An action spectrum for ultraviolet induced elastosis in hairless mice: quantification of elastosis by image analysis. Photochem Photobiol 1991; 53:237-42.
51. Fourtanier A, Bemerd F, Bouillon C et al. Protection of skin biological targets by different types of sunscreens. Photodermatol Photoimmunol Photomed 2006; 22:22-32.
52. Kligman LH, Agin PP, Sayre RM. Broad-spectrum sunscreens with UVAI and UVAII absorbers provide increased protection against solar simulation radiation-induced damage in hairless mice. J Soc Cosmet Chem 1996; 47:129-55.
53. Tsukahara K, Moriwaki S, Hotta M et al. The effect of sunscreen on skin elastase activity induced by ultraviolet-A irradiation. Biol Pharm Bull 2005; 28:2302-7.
54. Seite S, Moyal D, Richard S et al. Mexoryl SX: a broad absorption UVA filter protects human skin from the effects of repeated suberythemal doses of UVA. J Photochem Photobiol B 1998; 44:69-76.
55. Serre I, Cano JP, Picot MC et al. Immunosuppression induced by acute solar-simulated ultraviolet exposure in humans: prevention by a sunscreen with a sun protection factor of 15 and high UVA protection. J Am Acad Dermatol 1997; 37:187-94.
56. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-51.
57. Darlington S, WiUiams G, Neale R ct al. A randomized controlled trial to assess sunscreen appUcation and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139:451-5.
58. Wulf HC, Poulscn T, Brodthagcn H ct al. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dcmatol 1982; 7:194-202.
59. Ananthaswamy HN, Loughlin SM, Cox P et al. Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 1997; 3:510-4.
60. Krekels G, Voorter C, Kuik F et al. DNA-protection by sunscreens: p53-immunostaining. Eur J Dermatol 1997; 7:259-62.
61. Berne B, Ponten J, Ponten F. Decreased p53 expression in chronically sun-exposed human skin after topical photoprotection. Photodermatol Photoimmunol Photomed 1998; 14:148-53.
62. Ley RD, Fourtanier A. Sunscreen protection against ultraviolet radiation-induced pyrimidine dimers in mouse epidermal DNA. Photochem Photobiol 1997; 65:1007-11.
63. Fourtanier A. Mexoryl SX protects against solar-simulated UVR-induced photocarcinogenesis in mice. Photochem Photobiol 1996; 64:688-93.
64. Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999; 354:723-9.
65. Gallagher RP, Hill GB, Bajdik CD et al. Sunlight exposure, pigmentary factors and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131:157-63.
66. Westerdahl J, Olsson H, Masback A et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5:59-65.
67. Whiteman DC, Valery P, McWhirter W et al. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer 1997; 70:26-31.
68. Wolf P, Quehenberger F, Mulegger R et al. Phenotypic markers, sunhght-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian cas-control study. Melanoma Res 1998; 8:370-8.
69. Westerdahl J, Ingvar C, Masback A et al. Sunscreen use and maUgnant melanoma. Int J Cancer 2000; 87:145-50.
70. Diffey BL. Sunscreens and melanoma: The future looks bright. Br J Dermatol 2005; 153:378-81.
71. Huncharek M, Kupelnick B. Use of topical simscreens and the risk of malignant melanoma: a metaanalysis of 9067 patients from 11 case-control studies. Am J Public Health 2002; 92:1173-7.
72. Dennis LK, Beane Freeman LE, Van Beek MJ. Sunscreen use and the risk of melanoma: a quantitative review. Ann Intern Med 2003; 139:966-78.
73. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of pubUshed studies. Int J Cancer 1997; 73:198-203.
74. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 1999; 28:418-27.
75. Stem RS; PUVA Follow up study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44:755-61.
76. Gallagher RP, Rivers JK, Lee TK et al. Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trial. JAMA 2000; 283:2955-60.
77. Autier P, Dorc JF, Negrier S et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999; 91:1304-9.
78. Matsuoka LY, Wortman J, Hanifan N et al. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: a preliminary study. Arch Dermatol 1988; 124:1802-4.
79. MacLaughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 1982; 216:1001-3.
80. Marks R, Foley PA, Jolley D et al. The effects of regular sunscreen use on vitamin D levels in an Australian population: results of a randomized controlled trial. Arch Dermatol 1995; 131:415-21.
81. Farrerons J, Barnadas M, Rodriguez J et al. Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently cither to induce changes in parathyroid function or in metabolic markers. Br J Dermatol 1998; 139:422-7.
82. Sollitto RB, Kracmer KH, DiGiovanna JJ. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years* experience with xeroderma pigmentosum. J Am Acad Dermatol 1997; 37:942-7.
83. Yarosh D, Klein J, O'Connor A et al. EflFect of topically applied T4 endonucleasc V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357:926-9.
84. Stahl W, Krutmann J. Systemische Photoprotektion dutch Karotinoide. Hautarzt 2006; 57:281-5.
85. Leroy D. Les cremes solaires. Ann Dermatol Venereol 1999; 126:357-63.
86. McCarthy WH. The Australian experience in sun protection and screening for melanoma. J Surg Oncol 2004; 86:236-45.